A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis

Journal of the American Academy of Dermatology

Volumn 25, Issue 6, 1991, Pages 1145-1148

  Goldberg, Barbara ^a,b   Hartdegen, Richard ^a,b   Presbury, David ^a,b   Harvey Smith, Eric ^a,b   Yawalkar, Shantaram ^a,b  

^a Ciba Geigy AG ^*  (South Africa)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CORTICOSTEROID; ULOBETASOL PROPIONATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADULT; AGED; CHRONIC DISEASE; CLOBETASOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PATIENT SATISFACTION; PSORIASIS; REMISSION INDUCTION; SOUTH AFRICA; VASOCONSTRICTOR AGENTS; WOUND HEALING;

EID: 0025724093     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(91)70313-Q     Document Type: Article

References (3)

1. A double-blind multi-center comparison of 0.02% and 0.05% CGP 14 458 ointments and Dermovate ointment in patients with chronic psoriasis
2. Topical treatment of psoriasis with corticosteroids
3. Topical clobetasol 17-propionate: review of its clinical efficacy and safety